Lilly Sets Dates and Conference Calls for 2012 Financial Guidance and Fourth-Quarter 2011 Financial Results Announcements

INDIANAPOLIS, Dec. 16, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2012 on Thursday, January 5, 2012 and, separately, will announce its financial results for the fourth quarter and full year of 2011 on Tuesday, January 31, 2012.  On each day, Lilly will also conduct conference calls with the investment community and media to further detail the company's 2012 financial guidance and its 2011 financial performance, respectively.

The conference call on January 5th will begin at 9:30 a.m. EST while the conference call on January 31st will begin at 9:00 a.m. EST.  Investors, media and the general public can access a live webcast of the conference calls through links that will be posted on Lilly's website at www.lilly.com.  The webcasts of the conference calls will be available for replay through March 2, 2012.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.